A key aspect of successful viral vaccine design is the elicitation of neutralizing antibodies
targeting viral attachment and fusion glycoproteins that embellish viral particles. This …

The COVID-19 (coronavirus disease 2019) pandemic had an extensive impact on global
morbidity and mortality. Several other common respiratory viruses, such as the influenza …

Cell‐based influenza vaccines avoid egg‐adaptive mutations, potentially improving vaccine
effectiveness. We assessed the one‐season cost‐effectiveness of cell‐based quadrivalent …

The A/H1N1pdm09 influenza virus, which caused the 2009 pandemic, has since become a
recurring strain in seasonal influenza outbreaks. Given the ongoing threat of influenza …

Seasonal influenza significantly affects both health and economic costs in children and
adults. This narrative review summarizes published cost-effectiveness analyses (CEAs) of …

Influenza vaccines faced significant challenges in achieving sufficient protective efficacy and
production efficiency in the past. In recent decades, novel influenza vaccines, characterized …

ABSTRACT Objectives Annually in France, influenza results in over one million GP
consultations, around 20,000 hospitalizations, and approximately 9,000 deaths. This study …

Background Cell-based quadrivalent inactivated influenza vaccines (IIV4c) avoid egg-
adaptive mutations found in egg-based production, improving vaccine effectiveness (VE) …

Background Cell-based quadrivalent-inactivated influenza vaccine has been shown to have
higher vaccine effectiveness than traditional egg-based quadrivalent-inactivated influenza …

Background Antigenic similarity between vaccine viruses and circulating viruses is crucial
for achieving high vaccine effectiveness against seasonal influenza. New non-egg-based …